Additionally, for tumor types other than neuroblastoma, there is no assurance to collect 2 × 106 AP-CD34+ cells/kg when the PB-CD34+ cell counts are lower than 30 × 106 cells/L. This evidence concerns the gene CD34 and neuroblastoma.